BEIGF News and Press, BeiGene From 11/06/25

2025-11-06 15:17:04 ET More on BeiGene BeOne Medicines AG (ONC) Q3 2025 Earnings Call Transcript BeOne Medicines AG 2025 Q3 - Results - Earnings Call Presentation BeOne Medicines: Sonrotoclax Could Set Next Stage Of Growth For Hematology Pipeline BeiGene Non-...

2025-11-06 15:16:13 ET BeOne Medicines AG (ONC) Q3 2025 Earnings Call November 6, 2025 8:00 AM EST Company Participants Daniel Maller John Oyler - Co-Founder, Executive Chairman & CEO Aaron Rosenberg - Chief Financial Officer Wang Lai - Global Head of Res...

2025-10-14 16:24:38 ET The last time I spoke about BeOne Medicines AG ( ONC ), it was in a Seeking Alpha article entitled "BeiGene: TEVIMBRA European Push Continues With Positive CHMP Opinion." With respect to this article, I noted that it had received a positive opinion...

2025-10-13 09:08:36 ET More on BeiGene BeOne Medicines AG (ONC) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript) BeOne Medicines: Brukinsa's Leadership And Royalty Sale Signal A Stronger Future BeOne Medicines Ltd. 2025 Q2 - Results - ...

2025-09-15 20:21:09 ET This article is part of a series that provides an ongoing analysis of the changes made to Baker Brothers’ 13F stock portfolio on a quarterly basis. It is based on Baker Brothers’ regulatory 13F Form filed on 08/14/2025. The 13F portfolio value in...

2025-09-08 17:26:04 ET BeOne Medicines AG (ONC) Morgan Stanley 23rd Annual Global Healthcare Conference September 8, 2025 1:50 PM EDT... Read the full article on Seeking Alpha For further details see: BeOne Medicines AG (ONC) Presents At Morgan Stanley 23rd Annual Global Hea...

2025-09-08 09:47:45 ET It's been a little over three months since my last article, "Bristol-Myers Squibb At ASCO 2025: A Resilient Play Amid Market Turbulence." ... Read the full article on Seeking Alpha For further details see: Bristol-Myers Squibb: Why Q2 Results S...

2025-08-29 12:37:34 ET Since my last article, "Why AbbVie's Stock Is A Strong Buy After Q1 2025 Results," AbbVie's stock price (NYSE: ABBV ) (NEOE: ABBV:CA ) has risen 11.5%.... Read the full article on Seeking Alpha For further details see: AbbVie Smashes Ea...

2025-08-13 22:30:00 ET Investing Environment Global equities rallied during Q2, with major equity indices delivering strong double-digit returns, despite bouts of higher volatility amid lingering tariff uncertainty, the ongoing Russia-Ukraine war and a broadening of the Middle East ...

2025-08-06 13:37:33 ET More on BeiGene BeOne Medicines Ltd. (ONC) Q2 2025 Earnings Call Transcript BeOne Medicines: Competitive Advantage Of Zanubrutinib In The CLL Field BeOne Medicines beats top-line and bottom-line estimates; updates FY guidance BeiGene Q2...